- Home
- PBBK vs QNCX Comparison
PBBK vs QNCX Comparison
Compare PBBK & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBBK
- QNCX
- Stock Information
- Founded
- PBBK 1919
- QNCX 2012
- Country
- PBBK United States
- QNCX United States
- Employees
- PBBK N/A
- QNCX N/A
- Industry
- PBBK Banks
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PBBK Finance
- QNCX Health Care
- Exchange
- PBBK Nasdaq
- QNCX Nasdaq
- Market Cap
- PBBK 35.9M
- QNCX 34.4M
- IPO Year
- PBBK N/A
- QNCX 2019
- Fundamental
- Price
- PBBK $14.40
- QNCX $1.89
- Analyst Decision
- PBBK
- QNCX Strong Buy
- Analyst Count
- PBBK 0
- QNCX 3
- Target Price
- PBBK N/A
- QNCX $9.67
- AVG Volume (30 Days)
- PBBK 1.1K
- QNCX 1.4M
- Earning Date
- PBBK 11-13-2024
- QNCX 11-13-2024
- Dividend Yield
- PBBK N/A
- QNCX N/A
- EPS Growth
- PBBK N/A
- QNCX N/A
- EPS
- PBBK 0.64
- QNCX N/A
- Revenue
- PBBK $11,875,000.00
- QNCX N/A
- Revenue This Year
- PBBK N/A
- QNCX N/A
- Revenue Next Year
- PBBK N/A
- QNCX N/A
- P/E Ratio
- PBBK $22.93
- QNCX N/A
- Revenue Growth
- PBBK N/A
- QNCX N/A
- 52 Week Low
- PBBK $11.71
- QNCX $0.51
- 52 Week High
- PBBK $17.50
- QNCX $1.95
- Technical
- Relative Strength Index (RSI)
- PBBK 36.53
- QNCX 65.87
- Support Level
- PBBK $14.21
- QNCX $1.53
- Resistance Level
- PBBK $15.12
- QNCX $1.73
- Average True Range (ATR)
- PBBK 0.05
- QNCX 0.20
- MACD
- PBBK -0.01
- QNCX 0.01
- Stochastic Oscillator
- PBBK 40.84
- QNCX 74.81
About PBBK PB Bankshares Inc.
PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.